|
[1]
|
Elahi, N., Kamali, M. and Baghersad, M.H. (2018) Recent Biomedical Applications of Gold Nanoparticles: A Review. Talanta, 184, 537-556. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Mayer, K.M. and Hafner, J.H. (2011) Localized Surface Plasmon Resonance Sensors. Chemical Reviews, 111, 3828-3857. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Zhou, X., Liu, R., Qin, S., et al. (2016) Current Status and Future Direc-tions of Nanoparticulate Strategy for Cancer Immunotherapy. Current Drug Metabolism, 17, 755-762. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Chen, Y., Xianyu, Y. and Jiang, X. (2017) Surface Modification of Gold Nanoparticles with Small Molecules for Biochemical Analysis. Accounts of Chemical Research, 50, 310-319. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Alex, S. and Tiwari, A. (2015) Functionalized Gold Nanoparticles: Synthesis, Properties and Applications—A Review. Journal of Nanoscience and Nanotechnology, 15, 1869-1894. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Qian, H., Zhu, M., Wu, Z. and Jin, R.C. (2012) Quantum Sized Gold Nanoclusters with Atomic Precision. Accounts of Chemical Research, 45, 1470-1479. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Yuan, Q., Wang, Y., Zhao, L., et al. (2016) Peptide Protected Gold Clus-ters: Chemical Synthesis and Biomedical Applications. Nanoscale, 8, 12095-12104. [Google Scholar] [CrossRef]
|
|
[8]
|
Chen, X., Ren, X. and Gao, X. (2022) Peptide or Protein-Protected Metal Nanoclusters for Therapeutic Application. Chinese Journal of Chemistry, 40, 267-274. [Google Scholar] [CrossRef]
|
|
[9]
|
Tabatabaei, M.S., Islam, R. and Ahmed, M. (2021) Applications of Gold Nanoparticles in ELISA, PCR, and Immuno-PCR Assays: A Review. Analytica Chimica Acta, 1143, 250-266. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Kesharwani, P., Ma, R., Sang, L., et al. (2023) Gold Nanoparticles and Gold Nanorods in the Landscape of Cancer Therapy. Molecular Cancer, 22, Article No. 98. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Kumar, A., Zhang, X. and Liang, X.J. (2013) Gold Nanoparti-cles: Emerging Paradigm for Targeted Drug Delivery System. Biotechnology Advances, 31, 593-606. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Pasparakis, G. (2022) Recent Developments in the Use of Gold and Silver Nanoparticles in Biomedicine. Nanomedicine and Nanobiotechnology, 14, e1817. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Dasgupta, N. and Ranjan, S. (2018) An Introduction to Food Grade Nanoemulsions. Springer, Singapore. [Google Scholar] [CrossRef]
|
|
[14]
|
Rasmi, Y., Kırboğa, K.K., Khan, J., et al. (2023) Gold Nanoparti-cle-Based Strategies against SARS-CoV-2: A Review. Reviews on Advanced Materials Science, 62, Article ID: 20230105. [Google Scholar] [CrossRef]
|
|
[15]
|
Jans, H. and Huo, Q. (2012) Gold Nanoparticle-Enabled Biological and Chemical Detection and Analysis. Chemical Society Reviews, 41, 2849-2866. [Google Scholar] [CrossRef]
|
|
[16]
|
Draz, M.S. and Shafiee, H. (2018) Applications of Gold Nanoparticles in Virus Detection. Theranostics, 8, 1985-2017. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Wang, J., Drelich, A.J., Hopkins, C.M., et al. (2022) Gold Nanoparticles in Virus Detection: Recent Advances and Potential Considerations for SARS-CoV-2 Testing Development. Nanomedi-cine and Nanobiotechnology, 14, e1754. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Li, H. and Rothberg, L. (2004) Colorimetric Detection of DNA Sequences Based on Electrostatic Interactions with Unmodified Gold Nanoparticles. Proceedings of the National Academy of Sci-ences of the United States of America, 101, 14036-14039. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Shawky, S.M., Awad, A.M., Allam, W., et al. (2017) Gold Aggregating Gold: A Novel Nanoparticle Biosensor Approach for the Direct Quantification of Hepatitis C Virus RNA in Clinical Samples. Biosensors and Bioelectronics, 92, 349-356. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Lim, J., Nam, J., Yang, S., et al. (2015) Identification of Newly Emerging Influenza Viruses by Surface-Enhanced Raman Spectroscopy. Analytical Chemistry, 87, 11652-11659. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Zhang, H., Liu, L., Li, C.W., et al. (2011) Multien-zyme-Nanoparticles Amplification for Sensitive Virus Genotyping in Microfluidic Microbeads Array Using Au Nano-particle Probes and Quantum Dots as Labels. Biosensors and Bioelectronics, 29, 89-96. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Wang, H., Feng, N., Yang, S., et al. (2010) A Rapid Immuno-chromatographic Test Strip for Detecting Rabies Virus Antibody. Journal of Virological Methods, 170, 80-85. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Huang, C., Wen, T., Shi, F.J., et al. (2020) Rapid Detection of IgM Antibodies against the SARS-CoV-2 Virus via Colloidal Gold Nanoparticle-Based Lateral-Flow Assay. ACS Ome-ga, 5, 12550-12556. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Kim, J., Oh, S.Y., Shukla, S., et al. (2018) Heteroassembled Gold Nanoparticles with Sandwich-Immunoassay LSPR Chip Format for Rapid and Sensitive Detection of Hepatitis B Virus Surface Antigen (HBsAg). Biosensors and Bioelectronics, 107, 118-122. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Kurdekar, A.D., Avinash Chunduri, L.A., Manohar, C.S., et al. (2018) Streptavidin-Conjugated Gold Nanoclusters as Ultrasensitive Fluorescent Sensors for Early Diagnosis of HIV Infection. Science Advances, 4, eaar6280. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Ventura, B.D., Cennamo, M., Minopoli, A., et al. (2020) Colorimetric Test for Fast Detection of SARS-CoV-2 in Nasal and Throat Swabs. ACS Sensors, 5, 3043-3048. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Armesto, M., Charconnet, M., Marimón, J.M., et al. (2023) Vali-dation of Rapid and Economic Colorimetric Nanoparticle Assay for SARS-CoV-2 RNA Detection in Saliva and Naso-pharyngeal Swabs. Biosensors, 13, Article 275. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Trépo, C., Chan, H.L.Y. and Lok, A. (2014) Hepatitis B Virus Infec-tion. Lancet, 384, 2053-2063. [Google Scholar] [CrossRef]
|
|
[29]
|
DeHaan, E., McGowan, J.P., Fine, S.M., et al. (2022) PEP to Prevent HIV Infection. Johns Hopkins University, Baltimore.
|
|
[30]
|
Kurdekar, A., Chunduri, L.A.A., Bulagonda, E.P., et al. (2016) Comparative Performance Evaluation of Carbon Dot-Based Paper Immunoassay on Whatman Filter Paper and Nitrocellulose Paper in the Detection of HIV Infection. Microfluidics and Nanofluidics, 20, Article No. 99. [Google Scholar] [CrossRef]
|
|
[31]
|
Jain, P.K., Huang, W. and El-Sayed, M.A. (2007) On the Uni-versal Scaling Behavior of the Distance Decay of Plasmon Coupling in Metal Nanoparticle Pairs: A Plasmon Ruler Equa-tion. Nano Letters, 7, 2080-2088. [Google Scholar] [CrossRef]
|
|
[32]
|
Han, M.S., Byun, J.H., Cho, Y. and Rim, J.H. (2021) RT-PCR for SARS-CoV-2: Quantitative versus Qualitative. Lancet Infectious Diseases, 21, 165. [Google Scholar] [CrossRef]
|
|
[33]
|
Pashine, A., Valiante, N.M. and Ulmer, J.B. (2005) Target-ing the Innate Immune Response with Improved Vaccine Adjuvants. Nature Medicine, 11, S63-S68. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Wilson-Welder, J.H., Torres, M.P., Kipper, M.J., et al. (2009) Vaccine Adju-vants: Current Challenges and Future Approaches. Journal of Pharmaceutical Sciences, 98, 1278-1316. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Shi, S., Zhu, H., Xia, X., et al. (2019) Vaccine Adjuvants: Understanding the Structure and Mechanism of Adjuvanticity. Vaccine, 37, 3167-3178. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Dykman, L.A. and Khlebtsov, N.G. (2017) Immunological Properties of Gold Nanoparticles. Chemical Science, 8, 1719-1735. [Google Scholar] [CrossRef]
|
|
[37]
|
Liu, Y., Crawford, B.M. and Vo-Dinh, T. (2018) Gold Nanoparticles-Mediated Photothermal Therapy and Immunotherapy. Immunotherapy, 10, 1175-1188. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Salazar-González, J.A., Gonzá-lez-Ortega, O. and Rosales-Mendoza, S. (2015) Gold Nanoparticles and Vaccine Development. Expert Review of Vac-cines, 14, 1197-1211. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
De Almeida, R.R., Paim, B., De Oliveira, S.A., et al. (2017) Dengue Hemorrhagic Fever: A State-of-the-Art Review Focused in Pulmonary Involvement. Lung, 195, 389-395. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Bhatt, S., Gething, P.W., Brady, O.J., et al. (2013) The Global Distribution and Burden of Dengue. Nature, 496, 504-507. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Wahala, W.M.P.B., Kraus, A.A., Haymore, L.B., et al. (2009) Dengue Virus Neutralization by Human Immune Sera: Role of Envelope Protein Domain III-Reactive Antibody. Virology, 392, 103-113. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Fahimi, H., Mohammadipour, M., Haddad Kashani, H., et al. (2018) Dengue Viruses and Promising Envelope Protein Domain III-Based Vaccines. Applied Microbiology and Bio-technology, 102, 2977-2996. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Villar, L., Dayan, G.H., Arredondo-García, J.L., et al. (2015) Ef-ficacy of a Tetravalent Dengue Vaccine in Children in Latin America. New England Journal of Medicine, 372, 113-123. [Google Scholar] [CrossRef]
|
|
[44]
|
Quach, Q.H., Ang, S.K., Chu, J.H.J. and Kah, J.C.Y. (2018) Size-Dependent Neutralizing Activity of Gold Nanoparticle-Based Subunit Vaccine against Dengue Virus. Acta Bio-materialia, 78, 224-235. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Halstead, S.B. (2017) Dengvaxia Sensitizes Seronegatives to Vaccine Enhanced Disease Regardless of Age. Vaccine, 35, 6355-6358. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Awadasseid, A., Wu, Y., Tanaka, Y. and Zhang, W. (2021) Current Advances in the Development of SARS-CoV-2 Vaccines. International Journal of Biological Sciences, 17, 8-19. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Chen, D.Y., Chin, C.V., Kenney, D., et al. (2023) Spike and Nsp6 Are Key Determinants of SARS-CoV-2 Omicron BA.1 Attenuation. Nature, 615, 143-150. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Aguilar-Bretones, M., Fouchier, R.A., Koopmans, M.P., et al. (2023) Impact of Antigenic Evolution and Original Antigenic Sin on SARS-CoV-2 Immunity. Journal of Clinical Inves-tigation, 133, e162192. [Google Scholar] [CrossRef]
|
|
[49]
|
Fan, B., Gu, J., Deng, B., et al. (2023) Positively Charged-Amylose-Entangled Au-Nanoparticles Acting as Protein Carriers and Potential Adjuvants to SARS-CoV-2 Subunit Vaccines. ACS Applied Materials & Interfaces, 15, 29982-29997. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Bayani, F., Hashkavaei, N.S., Arjmand, S., et al. (2023) An Overview of the Vaccine Platforms to Combat COVID-19 with a Focus on the Subunit Vaccines. Progress in Biophysics and Mo-lecular Biology, 178, 32-49. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Niikura, K., Matsunaga, T., Suzuki, T., et al. (2013) Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses in Vitro and in Vivo. ACS Nano, 7, 3926-3938. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Polack, F.P., Thomas, S.J., Kitchin, N., et al. (2020) Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. New England Journal of Medicine, 383, 2603-2615. [Google Scholar] [CrossRef]
|
|
[53]
|
Tanriover, M.D., Doğanay, H.L., Akova, M., et al. (2021) Efficacy and Safety of an Inactivated Whole-Virion SARS-CoV-2 Vaccine (CoronaVac): Interim Results of a Double-Blind, Randomised, Placebo-Controlled, Phase 3 Trial in Turkey. Lancet, 398, 213-222. [Google Scholar] [CrossRef]
|
|
[54]
|
Knoll, M.D. and Wonodi, C. (2021) Oxford-AstraZeneca COVID-19 Vaccine Efficacy. Lancet, 397, 72-74. [Google Scholar] [CrossRef]
|
|
[55]
|
Song, J.Y., Choi, W.S., Heo, J.Y., et al. (2022) Safety and Immunogenicity of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) Adjuvanted with AS03: A Randomised, Placebo-Controlled, Observer-Blinded Phase 1/2 Trial. eClinicalMedicine, 51, Article ID: 101569. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Dreaden, E.C., Austin, L.A., Mackey, M.A. and El-Sayed, M.A. (2012) Size Matters: Gold Nanoparticles in Targeted Cancer Drug Delivery. Therapeutic Delivery, 3, 457-478. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Goddard, Z.R., Marín, M.J., Russell, D.A. and Searcey, M. (2020) Active Targeting of Gold Nanoparticles as Cancer Therapeutics. Chemical Society Reviews, 49, 8774-8789. [Google Scholar] [CrossRef]
|
|
[58]
|
Yazdanpanah, Y., Fagard, C., Descamps, D., et al. (2009) High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial. Clinical Infectious Diseases, 49, 1441-1449. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Chun, T.W., Moir, S. and Fauci, A.S. (2015) HIV Reservoirs as Obstacles and Opportunities for an HIV Cure. Nature Immunology, 16, 584-589. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Garrido, C., Simpson, C.A., Dahl, N.P., et al. (2015) Gold Nanoparticles to Improve HIV Drug Delivery. Future Medicinal Chemistry, 7, 1097-1107. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Kalimuthu, K., Lubin, B.C., Bazylevich, A., et al. (2018) Gold Nanoparti-cles Stabilize Peptide-Drug-Conjugates for Sustained Targeted Drug Delivery to Cancer Cells. Journal of Nanobiotech-nology, 16, Article No. 34. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Fratoddi, I., Venditti, I., Battocchio, C., et al. (2019) Highly Hy-drophilic Gold Nanoparticles as Carrier for Anticancer Copper(I) Complexes: Loading and Release Studies for Biomedi-cal Applications. Nanomaterials, 9, Article 772. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Fotooh Abadi, L., Kumar, P., Paknikar, K., et al. (2023) Tenofo-vir-Tethered Gold Nanoparticles as a Novel Multifunctional Long-Acting Anti-HIV Therapy to Overcome Deficient Drug Delivery-: An in Vivo Proof of Concept. Journal of Nanobiotechnology, 21, Article No. 19. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Bowman, M.C., Ballard, T.E., Ackerson, C.J., et al. (2008) In-hibition of HIV Fusion with Multivalent Gold Nanoparticles. Journal of the American Chemical Society, 130, 6896-6897. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Li, F., Huang, Q., Zhou, Z., et al. (2023) Gold Nanoparticles Combat Enveloped RNA Virus by Affecting Organelle Dynamics. Signal Transduction and Targeted Therapy, 8, Article No. 285. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Jit, M., Prem, K., Benard, E. and Brisson, M. (2021) From Cervical Cancer Elimination to Eradication of Vaccine-Type Human Papillomavirus: Feasibility, Public Health Strategies and Cost-Effectiveness. Preventive Medicine, 144, Article ID: 106354. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Valencia-Reséndiz, D.G., Villegas, A., Bahena, D., et al. (2022) Non-Functionalized Gold Nanoparticles Inhibit Human Papillomavirus (HPV) Infection. International Journal of Molec-ular Sciences, 23, Article 7552. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Giroglou, T., Florin, L., Schäfer, F., et al. (2001) Human Papilloma-virus Infection Requires Cell Surface Heparan Sulfate. Journal of Virology, 75, 1565-1570. [Google Scholar] [CrossRef]
|
|
[70]
|
Yan, F.F. and Gao, F. (2021) An Overview of Potential In-hibitors Targeting Non-Structural Proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2. Computational and Structural Biotechnology Journal, 19, 4868-4883. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Su, H., Zhou, F., Huang, Z., et al. (2021) Molecular Insights into Small-Molecule Drug Discovery for SARS-CoV-2. Angewandte Chemie, 60, 9789-9802. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
He, Z., Ye, F., Zhang, C., et al. (2022) A Comparison of Remdesivir versus Gold Cluster in COVID-19 Animal Model: A Better Therapeutic Outcome of Gold Cluster. Nano Today, 44, Ar-ticle ID: 101468. [Google Scholar] [CrossRef] [PubMed]
|
|
[73]
|
Mehta, P., McAuley, D.F., Brown, M., et al. (2020) COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression. Lancet, 395, 1033-1034. [Google Scholar] [CrossRef]
|
|
[74]
|
Lv, T., Cao, W. and Li, T. (2021) HIV-Related Immune Ac-tivation and Inflammation: Current Understanding and Strategies. Journal of Immunology Research, 2021, Article ID: 7316456. [Google Scholar] [CrossRef] [PubMed]
|
|
[75]
|
Yang, G., Wan, P., Zhang, Y., et al. (2022) Innate Immunity, Inflammation, and Intervention in HBV Infection. Viruses, 14, Article 2275. [Google Scholar] [CrossRef] [PubMed]
|
|
[76]
|
Yuan, Q., Gao, F., Yao, Y., et al. (2019) Gold Clusters Prevent Inflamma-tion-Induced Bone Erosion through Inhibiting the Activation of NF-κB Pathway. Theranostics, 9, 1825-1836. [Google Scholar] [CrossRef] [PubMed]
|
|
[77]
|
Liu, Y., Meng, C., Li, Y., et al. (2023) Peptide-Protected Gold Nanoclus-ters Efficiently Ameliorate Acute Contact Dermatitis and Psoriasis via Repressing the TNF-α/NF-κB/IL-17A Axis in Keratinocytes. Nanomaterials, 13, Article 662. [Google Scholar] [CrossRef] [PubMed]
|
|
[78]
|
Yañez-Aulestia, A., Gupta, N.K., Hernández, M., et al. (2022) Gold Nanoparticles: Current and Upcoming Biomedical Applications in Sens-ing, Drug, and Gene Delivery. Chemical Communications, 58, 10886-10895. [Google Scholar] [CrossRef]
|